Serotonin mediates rapid changes of striatal glucose and lactate metabolism after systemic 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") administration in awake rats

Neurochemistry International

Volumn 51, Issue 1, 2007, Pages 8-15

  Gramsbergen, Jan Bert ^a   Cumming, Paul ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Amphetamine; Ecstasy; Energy metabolism; Glucose sensor; Hyperthermia; Lactate sensor; Microdialysis; Neurotoxicity; Serotonin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; FENCLONINE; GLUCOSE; LACTIC ACID; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; BIOSENSOR; BLOOD SAMPLING; BODY TEMPERATURE; CONTROLLED STUDY; CORPUS STRIATUM; ENERGY METABOLISM; FLOW INJECTION ANALYSIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HYPERTHERMIA; LACTATE BLOOD LEVEL; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; TELEMETRY;

ANIMALS; BODY TEMPERATURE; CORPUS STRIATUM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENERGY METABOLISM; EXTRACELLULAR FLUID; FENCLONINE; FEVER; GLUCOSE; LACTIC ACID; MALE; MICRODIALYSIS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGENTS; SEROTONIN ANTAGONISTS; TIME FACTORS; WAKEFULNESS;

RATTUS;

EID: 34347238884     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2007.03.004     Document Type: Article

References (47)

1. Beitia G., Cobreros A., Sainz L., and Cenarruzabeitia E. Ecstasy-induced toxicity in rat liver. Liver 20 (2000) 8-15
2. Blessing W.W., Seaman B., Pedersen N.P., and Ootsuka Y. Clozapine reverses hyperthermia and sympathetically mediated cutaneous vasoconstriction induced by 3,4-methylenedioxymethamphetamine (ecstasy) in rabbits and rats. J. Neurosci. 23 (2003) 6385-6391
3. Brown J.M., and Yamamoto B.K. Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress. Pharmacol. Ther. 99 (2003) 45-53
4. Bull E.J., Porkess V., Rigby M., Hutson P.H., and Fone K.C. Pre-treatment with 3,4-methylenedioxymethamphetamine (MDMA) causes long-lasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain. J. Psychopharmacol. 20 (2006) 272-280
5. Colado M.I., Granados R., O'Shea E., Esteban B., and Green A.R. The acute effect in rats of 3,4-methylenedioxyethamphetamine (MDEA, "eve") on body temperature and long term degeneration of 5-HT neurones in brain: a comparison with MDMA ("ecstasy"). Pharmacol. Toxicol. 84 (1999) 261-266
6. Colado M.I., O'Shea E., Granados R., Esteban B., Martin A.B., and Green A.R. Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration. Br. J. Pharmacol. 126 (1999) 911-924
7. Darvesh A.S., and Gudelsky G.A. Activation of 5-HT2 receptors induces glycogenolysis in the rat brain. Eur. J. Pharmacol. 464 (2003) 135-140
8. Darvesh A.S., and Gudelsky G.A. Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT. Brain Res. 1056 (2005) 168-175
9. Darvesh A.S., Shankaran M., and Gudelsky G.A. 3,4-Methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain. J. Pharmacol. Exp. Ther. 301 (2002) 138-144
10. Darvesh A.S., Yamamoto B.K., and Gudelsky G.A. Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain. J. Pharmacol. Exp. Ther. 312 (2005) 694-701
11. Dienel G.A., and Cruz N.F. Nutrition during brain activation: does cell-to-cell lactate shuttling contribute significantly to sweet and sour food for thought?. Neurochem. Int. 45 (2004) 321-351
12. Dringen R., Gebhardt R., and Hamprecht B. Glycogen in astrocytes: possible function as lactate supply for neighboring cells. Brain Res. 623 (1993) 208-214
13. Ferrington L., Kirilly E., McBean D.E., Olverman H.J., Bagdy G., and Kelly P.A. Persistent cerebrovascular effects of MDMA and acute responses to the drug. Eur. J. Neurosci. 24 (2006) 509-519
14. Fischer C., Hatzidimitriou G., Wlos J., Katz J., and Ricaurte G. Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). J. Neurosci. 15 (1995) 5476-5485
15. Fischer Y., Thomas J., Kamp J., Jungling E., Rose H., Carpene, and Kammermeier H. 5-hydroxytryptamine stimulates glucose transport in cardiomyocytes via a monoamine oxidase-dependent reaction. Biochem. J. 311 Pt 2 (1995) 575-583
16. Gamma A., Buck A., Berthold T., Liechti M.E., and Vollenweider F.X. 3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humans. Neuropsychopharmacology 23 (2000) 388-395
17. Gramsbergen J.B., Skjøth-Rasmussen J., Rasmussen C., and Lambertsen K.L. On-line monitoring of striatum glucose and lactate in the endothelin-1 rat model of transient, focal cerebral ischemia using microdialysis and flow-injection analysis with biosensors. J. Neurosci. Methods 140 (2004) 93-101
18. Green A.R., Mechan A.O., Elliott J.M., O'Shea E., and Colado M.I. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol. Rev. 55 (2003) 463-508
19. Gruetter R. Glycogen: the forgotten cerebral energy store. J. Neurosci. Res. 74 (2003) 179-183
20. Hajduch E., Rencurel F., Balendran A., Batty I.H., Downes C.P., and Hundal H.S. Serotonin (5-Hydroxytryptamine), a novel regulator of glucose transport in rat skeletal muscle. J. Biol. Chem. 274 (1999) 13563-13568
21. Herin D.V., Liu S., Ullrich T., Rice K.C., and Cunningham K.A. Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine. Psychopharmacology (Berl) 178 (2005) 505-513
22. Hervias I., Lasheras B., and Aguirre N. 2-Deoxy-d-glucose prevents and nicotinamide potentiates 3,4-methylenedioxymethamphetamine-induced serotonin neurotoxicity. J. Neurochem. 75 (2000) 982-990
23. Hilber B., Scholze P., Dorostkar M.M., Sandtner W., Holy M., Boehm S., Singer E.A., and Sitte H.H. Serotonin-transporter mediated efflux: a pharmacological analysis of amphetamines and non-amphetamines. Neuropharmacology 49 (2005) 811-819
24. Jope R.S., and Johnson G.V. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 29 (2004) 95-102
25. Kiyatkin E.A. Brain hyperthermia as physiological and pathological phenomena. Brain Res. Brain Res. Rev. 50 (2005) 27-56
26. Kong E.K., Peng L., Chen Y., Yu A.C., and Hertz L. Up-regulation of 5-HT2B receptor density and receptor-mediated glycogenolysis in mouse astrocytes by long-term fluoxetine administration. Neurochem. Res. 27 (2002) 113-120
27. Korf J. Intracerebral trafficking of lactate in vivo during stress, exercise, electroconvulsive shock and ischemia as studied with microdialysis. Dev. Neurosci. 18 (1996) 405-414
28. Leegsma-Vogt G., Venema K., and Korf J. Evidence for a lactate pool in the rat brain that is not used as an energy supply under normoglycemic conditions. J. Cereb. Blood Flow Metab. 23 (2003) 933-941
29. Li X., Zhu W., Roh M.S., Friedman A.B., Rosborough K., and Jope R.S. In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain. Neuropsychopharmacology 29 (2004) 1426-1431
30. Lin M.T., and Shian L.R. Stimulation of 5-hydroxytryptamine nerve cells in dorsal and median raphe nuclei elevates blood glucose in rats. Pflugers Arch. 417 (1991) 441-445
31. Moore M.C., DiCostanzo C.A., Dardevet D., Lautz M., Farmer B., and Cherrington A.D. Interaction of a selective serotonin reuptake inhibitor with insulin in the control of hepatic glucose uptake in conscious dogs. Am. J. Physiol. Endocrinol. Metab. 288 (2005) E556-E563
32. Morgan M.J. Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology (Berl) 152 (2000) 230-248
33. Nixdorf W.L., Burrows K.B., Gudelsky G.A., and Yamamoto B.K. Enhancement of 3,4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate. J. Neurochem. 77 (2001) 647-654
34. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. second ed. (1986), Academic Press, New York
35. Pellerin L., and Magistretti P.J. Food for thought: challenging the dogmas. J. Cereb. Blood Flow Metab. 23 (2003) 1282-1286
36. Quate L., McBean D.E., Ritchie I.M., Olverman H.J., and Kelly P.A. Acute methylenedioxymethamphetamine administration: effects on local cerebral blood flow and glucose utilisation in the Dark Agouti rat. Psychopharmacology (Berl) 173 (2004) 287-295 (Epub 2004 Feb 2020)
37. Rosa-Neto P., Olsen A.K., Gjedde A., Watanabe H., and Cumming P. MDMA-evoked changes in cerebral blood flow in living porcine brain: correlation with hyperthermia. Synapse 53 (2004) 214-221
38. Saadat K.S., Elliott J.M., Colado M.I., and Green A.R. Hyperthermic and neurotoxic effect of 3,4-methylenedioxymethamphetamine (MDMA) in guinea pigs. Psychopharmacology (Berl) 173 (2004) 452-453
39. Schmued L.C. Demonstration and localization of neuronal degeneration in the rat forebrain following a single exposure to MDMA. Brain Res. 974 (2003) 127-133
40. Schreckenberger M., Gouzoulis-Mayfrank E., Sabri O., Arning C., Zimny M., Zeggel T., Wagenknecht G., Kaiser H.J., Sass H., and Buell U. "Ecstasy"-induced changes of cerebral glucose metabolism and their correlation to acute psychopathology. An 18-FDG PET study. Eur. J. Nucl. Med. 26 (1999) 1572-1579
41. Schurr A. Lactate: the ultimate cerebral oxidative energy substrate?. J. Cereb. Blood Flow Metab. 26 (2006) 142-152
42. Sloot W.N., and Gramsbergen J.B. Detection of salicylate and its hydroxylated adducts 2,3- and 2,5-dihydroxybenzoic acids as possible indices for in vivo hydroxyl radical formation in combination with catechol- and indoleamines and their metabolites in cerebrospinal fluid and brain tissue. J. Neurosci. Methods 60 (1995) 141-149
43. Smith G.S., Ma Y., Dhawan V., Gunduz H., Carbon M., Kirshner M., Larson J., Chaly T., Belakhleff A., Kramer E., Greenwald B., Kane J.M., Laghrissi-Thode F., Pollock B.G., and Eidelber D. Serotonin modulation of cerebral glucose metabolism measured with positron emission tomography (PET) in human subjects. Synapse 45 (2002) 105-112
44. Spatz M., Mrsulja B.B., Wroblewska B., Merkel N., and Bembry J. Modulation of glycogen metabolism in cerebromicrovascular smooth muscle and endothelial cultures. Biochem. Biophys. Res. Commun. 134 (1986) 484-491
45. Stephans S.E., Whittingham T.S., Douglas A.J., Lust W.D., and Yamamoto B.K. Substrates of energy metabolism attenuate methamphetamine-induced neurotoxicity in striatum. J. Neurochem. 71 (1998) 613-621
46. Wilkerson G., and London E.D. Effects of methylenedioxymethamphetamine on local cerebral glucose utilization in the rat. Neuropharmacology 28 (1989) 1129-1138
47. Yuan J., Cord B.J., McCann U.D., Callahan B.T., and Ricaurte G.A. Effect of glucoprivation on serotonin neurotoxicity induced by substituted amphetamines. J. Pharmacol. Exp. Ther. 303 (2002) 831-839